Pilot Study With GFT505 (80mg) in Patients With Insulin Resistance and Abdominal Obesity

PHASE2CompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

January 31, 2011

Primary Completion Date

November 30, 2011

Study Completion Date

November 30, 2011

Conditions

Insulin ResistanceAbdominal Obesity

Interventions

DRUG

GFT505 80mg

hard gelatin capsules dosed at 20mg, oral administration, 4 capsules per day before breakfast

DRUG

Placebo

hard gelatin capsules, oral administration, 4 capsules per day before breakfast

Trial Locations (2)

Site n°1, Nantes

Site n°2, Pierre-Bénite